|
You gotta have heart!
02-10-2015
EDIT CONNECT
SHARING OPTIONS:
FORT LAUDERDALE-DAVIE,
Fla.—Nova Southeastern University (NSU) researchers recently discovered that,
contrary to prior belief, tissues of different mammalian organs have very different abilities to repair damage to their DNA.
These new findings indicate that the heart has the greatest capacity to repair its DNA, followed by the intestines, kidneys, spleen, testes, and
lungs. The brain, however, exhibited no ability to repair damage to its DNA.
These studies were performed in
murine cell tissue culture, but, based on previous human studies performed by the same investigators, such “tissue specificity” is true of
humans, as well.
Using skin as the control, the researchers exposed growing cells derived from each of these
tissues to a defined dose of ultraviolet (UVC) light, the part of normal sunlight that causes extensive DNA damage. Although there are five types of
DNA repair performed by mammalian cells, the investigators then specifically measured the amount of repair performed by one type called nucleotide excision
repair.
This type of DNA repair is a complicated process that requires a high level of metabolic investment by the
cell. Brain cells may focus their energies on other more essential activities, and are not commonly exposed to UVC light, perhaps explaining their
undetectable level of repair.
“The human body was not designed to live past 30 or 40 years, so our brains
haven’t prioritized DNA repair over other necessary functions,” said lead investigator Jean Latimer, Ph.D., associate professor of pharmaceutical
sciences, NSU’s College of Pharmacy. “Our brains are frequently not physically prepared to last as long as medical science is now allowing our
bodies to live. These findings could help explain a root cause behind memory loss and dementia.”
The
research team consisted of Latimer; Stephen Grant, Ph.D., associate professor of public health, NSU’s College of Osteopathic Medicine; NSU College of
Pharmacy students Vongai Majekwana, Pharm.D. candidate; and Yashira Pabón-Padín, Pharm.D. candidate; and Manasi Pimpley, Ph.D.
candidate.
Their findings are published in the peer-reviewed journal, Photochemistry and Photobiology in
an article titled “Regulation and dysregulation of mammalian nucleotide excision repair: a pathway to non-germline breast carcinogenesis.” The
full article is available at http://onlinelibrary.wiley.com/doi/10.1111/php.12387/full.
In the article abstract, the authors explain
that nucleotide excision repair (NER) is an important modulator of disease, especially in constitutive deficiencies such as the cancer predisposition
syndrome Xeroderma pigmentosum. The authors found “profound variation in NER capacity among normal individuals, between cell-types and during
carcinogenesis. NER is a repair system for many types of DNA damage, and therefore http://www.nova.edu/many types of genotoxic carcinogenic exposures, including ultraviolet light, products of organic combustion, metals and oxidative
stress. Because NER is intimately related to cellular metabolism, requiring components of both the DNA replicative and transcription machinery, it has a
narrow range of functional viability. Thus, genes in the NER pathway are expressed at the low levels manifested by, for example, nuclear transcription
factors. As NER activity and gene expression vary by cell type, it is inherently epigenetically regulated. Furthermore, this epigenetic modulation is
dysregulated during sporadic breast carcinogenesis. Loss of NER is one basis of genomic instability, a required element in cellular transformation, and one
that potentially influences response to therapy. In this study, we demonstrate differences in NER capacity in eight adult mouse tissues, and place this
result into the context of our previous work on mouse extraembryonic tissues, normal human tissues and sporadic early stage human breast
cancer.”
This study was also supported by the Ruth Estrin Goldberg Foundation and a President’s
Faculty Research and Development Grant from NSU.
Code: E02111502 Back |
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|